News

Clinical Trials Arena21h
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Clinical Trials Arena23h
ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares
ANI Pharmaceuticals has commenced a Phase IV trial to compare two dosage levels of Purified Cortrophin Gel for acute gout ...